Edgewise Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 15.02 M | $400.93 M | 0.00% | 16.01% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 8.91 M | $237.78 M | 0.00% | 9.50% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.39 M | $170.64 M | 100.00% | 6.82% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 5.84 M | $155.87 M | 0.00% | 6.23% |
| NOVO HOLDINGS A/S | 10/24/2024 | 5.55 M | $148.13 M | -12.52% | 5.92% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.56 M | $121.62 M | 74.84% | 4.86% |
| VANGUARD GROUP INC | 11/13/2024 | 4.52 M | $120.53 M | 0.18% | 4.81% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 3.41 M | $90.92 M | 13.30% | 3.63% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 2.83 M | $75.61 M | -24.07% | 3.02% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 2.79 M | $74.44 M | 19.94% | 2.97% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.33 M | $62.20 M | 25.53% | 2.48% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 2.11 M | $56.40 M | -7.03% | 2.25% |
| BRAIDWELL LP | 11/14/2024 | 1.96 M | $52.27 M | 100.00% | 2.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.95 M | $52.14 M | 54.99% | 2.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 1.78 M | $47.54 M | -38.04% | 1.90% |
| STATE STREET CORP | 11/14/2024 | 1.69 M | $44.98 M | 1.20% | 1.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.60 M | $42.70 M | -4.37% | 1.71% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 11/13/2024 | 1.55 M | $41.47 M | 0.00% | 1.66% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 1.48 M | $39.53 M | 0.00% | 1.58% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.43 M | $38.14 M | 0.00% | 1.52% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.25 M | $33.37 M | 0.00% | 1.33% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 1.10 M | $29.37 M | 490.46% | 1.17% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 1.00 M | $26.71 M | 100.00% | 1.07% |
| VR ADVISER, LLC | 11/14/2024 | 1.00 M | $26.69 M | -45.00% | 1.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 987,030 | $26.34 M | -13.83% | 1.05% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 934,387 | $24.94 M | 8.64% | 1.00% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 917,166 | $24.48 M | 23.83% | 0.98% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 820,200 | $21.89 M | 100.00% | 0.87% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 726,871 | $19.40 M | 55.48% | 0.77% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 657,070 | $17.54 M | 14.37% | 0.70% |
| FMR LLC | 11/13/2024 | 653,208 | $17.43 M | -86.34% | 0.70% |
| MARSHALL WACE, LLP | 11/14/2024 | 577,565 | $15.42 M | 38.93% | 0.62% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 545,546 | $14.56 M | 598.22% | 0.58% |
| CITADEL ADVISORS LLC | 11/14/2024 | 538,249 | $14.37 M | -77.09% | 0.57% |
| WOODLINE PARTNERS LP | 11/14/2024 | 527,839 | $14.09 M | 25.20% | 0.56% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 522,500 | $13.95 M | -9.91% | 0.56% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 522,086 | $13.93 M | -8.60% | 0.56% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 511,905 | $13.66 M | -27.97% | 0.55% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 500,000 | $13.35 M | 100.00% | 0.53% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 482,225 | $12.87 M | -70.28% | 0.51% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 455,348 | $12.15 M | 46.19% | 0.49% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 450,000 | $12.01 M | 100.00% | 0.48% |
| MORGAN STANLEY | 11/14/2024 | 418,131 | $11.16 M | 67.27% | 0.45% |
| SIREN, L.L.C. | 11/13/2024 | 404,113 | $10.79 B | 100.00% | 0.43% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 384,767 | $10.27 B | -19.11% | 0.41% |
| JANE STREET GROUP, LLC | 11/15/2024 | 379,600 | $10.13 M | 100.00% | 0.40% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 308,051 | $8.22 M | 12.92% | 0.33% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 299,369 | $7.99 M | 1,130.91% | 0.32% |
| CANDRIAM S.C.A. | 11/13/2024 | 294,624 | $7.86 M | -10.45% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 270,406 | $7.22 M | 11.23% | 0.29% |
Edgewise Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 184 institutional investors and hedge funds held shares of Edgewise Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 15.02 M
RA CAPITAL MANAGEMENT, L.P.: 8.91 M
BlackRock Funding, Inc. /DE: 6.39 M
BAKER BROS. ADVISORS LP: 5.84 M
Novo Holdings A/S: 5.55 M
JANUS HENDERSON GROUP PLC: 4.56 M
107.99% of Edgewise Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 106.52 M shares in the last 24 months. This purchase volume represents approximately $2.93 B in transactions.